A Pilot Study of the Effects of Active VItamin D on Left Atrial Volume Index in Patients With Heart Failure and Preserved Ejection Fraction
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 15 Aug 2013
At a glance
- Drugs Paricalcitol (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- Acronyms AVID-LAVI
- 10 Jun 2017 Biomarkers information updated
- 15 Aug 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 18 Jan 2013 Planned initiation date changed from 1 Aug 2012 to 1 Mar 2014 as reported by ClinicalTrials.gov.